Modified 'smallpox vaccine' virus triples liver cancer survival time Newstrack India London, February 11(ANI): The virus used in the vaccine that helped eradicate smallpox is offering new hope to liver cancer patients. Researchers have found that a genetically engineered version of the vaccinia virus tripled the average survival time ... |
